Interleukin-6, interleukin-8, and interleukin-10 in kidney transplantation: improved risk strategy?
Diller
R
R
Surgical Research, Department of General Surgery, Muenster University Hospital, Muenster, Germany. diller@uni-muenster.de
Palmes
D
D
Dietl
K-H
KH
Senninger
N
N
Winde
G
G
Spiegel
H-U
HU
D000328:Adult; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016753:Interleukin-10 / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood*; D016209:Interleukin-8 / Q000097:blood*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D015166:Monitoring, Immunologic; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D012016:Reference Values; D012044:Regression Analysis; D012189:Retrospective Studies; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D015850:Interleukin-6; D016209:Interleukin-8; D016753:Interleukin-10